Replicel

[WashedOut]

Will they know if this will be compoundable from their first data, or will this come later in the trails? I hope it is, because % would not be an issue (:

I hope they answer that too. I can't understand why it wouldn't be compoundable but who knows how these things work out. Even 30% is pretty good, still better than dealing with surgery and you could use a thickener to make it look more like 60%+. Also, once it becomes a proven technology it will advance so it could reach much higher percentages with time.

[alex123]

The stock price of this company continues to plummet, against the trend of the market which has been upwards. It seems likely that some insiders are selling off their shares.

[Have Hope3]

The stock price of this company continues to plummet, against the trend of the market which has been upwards. It seems likely that some insiders are selling off their shares.

Alex, this stock drop does seem to be a bit troubling. I hope it is just some day trading going on but the volume of trades per day seems to be way up. The stock did end the day on a upswing! Cmon RepliCel pull through for us!

[ccmethinning]

I'm not sure if the rule applies to small, OTC companies like Replicel, but don't insiders have to file before they sell their shares?

[Maradona]

Guys the stock plummeting is kinda worrisome and the leak info is probably fake. I've talked to one representative of replicel , he said there's no way information has been leaked, since its a double placebo bla bla bla something along the lines.

Keep hope alive guys, just come back in march, this company could be the next microsoft !

Unless they didn't use the correct injection procedure.....there's nothing to worry about...yet.

and About Aderans....they had a bunch of trials....they still were going to finish phase 2 next year...that was no news. But I don't think their procedure is as good as replicel at least in theory, they're now doing trial and error...hopefully replicel doesn't have to go through that or we are !@*#ed.

[PinotQ]

Several of us posted on this about a week ago and the stock price has indeed continued to fall. It is now at about a 12 month low. I have been accumulating shares over the last year so I have followed this closely. It is discomforting to see the stock price falling this close to the release of the trial results as I would have expected it to be trending in a positive direction. However it is very difficult to definitively read anything into this. There are about 44 million shares outstanding with about 24 million of those shares that have been granted to upper management locked in a trust (they begin to be released quarterly after Q1 2012). That leaves about 20 million shares currently available for trading. So unless upper management has purchased shares on the market, they would not likely be selling. On January 6th 2012, the stock closed at $2.40. It closed at $1.80 yesterday representing a 25% drop in less than a month. The average number of shares traded using a moving 10 day average is currently just over 9,000 shares traded per day. It was much less than this prior to January 6th. This represents about .04% of the stock trading per day. If you multiply this amount by the number of days the stock has been trading since it began to drop on Jan. 6th, only 180,000 shares or .75% of the 24 million shares available to be traded, have changed hands during this downward swing. So relatively speaking, this is insignificant. At the same time, the types of "insiders" that could potentially be trading in the stock is also probably insignificant. For example, the trial participants, employees associated with conducting the trial, etc. While the trial is double blinded, the company conducting the trial has already reported to Replicel that there have been no adverse events. It could easily have also reported to Replicel that they see no visible evidence of any difference in regrowth between the 2 test sites on each of the subjects scalps. So it's anybody's guess as to why the stock is dropping. If there is insider trading, I do not believe that it is by upper management or those in control of the company. They seem to be very well run, professional and organized. So if there is insider trading it would have to be those on the periphery.

[PinotQ]

Correction, The above post should read: " is currently just over 9,000 shares traded per day. It was much less than this prior to January 6th. This represents about .05% of the stock trading per day."

and

" ....only 180,000 shares or .9% of the 20 million shares available to be traded...."

[born]

Correction, The above post should read: " is currently just over 9,000 shares traded per day. It was much less than this prior to January 6th. This represents about .05% of the stock trading per day."

and

" ....only 180,000 shares or .9% of the 20 million shares available to be traded...."

so ? is this bad ?

[MackJames]

Guys the stock plummeting is kinda worrisome and the leak info is probably fake. I've talked to one representative of replicel , he said there's no way information has been leaked, since its a double placebo bla bla bla something along the lines.

Keep hope alive guys, just come back in march, this company could be the next microsoft !

Unless they didn't use the correct injection procedure.....there's nothing to worry about...yet.

and About Aderans....they had a bunch of trials....they still were going to finish phase 2 next year...that was no news. But I don't think their procedure is as good as replicel at least in theory, they're now doing trial and error...hopefully replicel doesn't have to go through that or we are !@*#ed.

This technology is literally untested and Replicel, in its current incarnation, a relatively new company. Some investors might consider the market for a product like this to be limited, which is in my opinion extremely short sighted on their part. Many investors might be hesitant to gamble on this stock until some kind of results are published, which is another major mistake.

As an investor myself, these kind of companies can be pretty attractive, but are admittedly a serious risk. Investing in a company while they are small and haven't attracted much mainstream attention could lead to big returns if the product works. If you are going to buy, I would recommend doing so before the results of phase I of the clinical trials are released, but be prepared to lose your money if the results are a bust. Investing is a risk but taking risk is what makes the millionaires. Rule of thumb, never invest more than you are willing to risk, and be prepared to lose money.

[PinotQ]

Great advice MackJames! That is exactly my strategy. I am fully prepared to lose it all and, if so, it won't hurt too much. But I think you could search for a long time before you find something with an upside like this. Given the emotion attached to this issue and the fact that by most accounts less than 2-10% seek treatment for lack of something that really works, and throw in the female market and you have an incredible upside.

Born, My point here is that 99% of the shares have not been sold over this downturn so that is a plus indicator if you are rooting for Replicel.